These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9784323)

  • 1. Analysis of allelic imbalance on chromosome 17p13 in stage I and stage II epithelial ovarian cancers.
    Wiper DW; Zanotti KM; Kennedy AW; Belinson JL; Casey G
    Gynecol Oncol; 1998 Oct; 71(1):77-82. PubMed ID: 9784323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2.
    Schultz DC; Vanderveer L; Buetow KH; Boente MP; Ozols RF; Hamilton TC; Godwin AK
    Cancer Res; 1995 May; 55(10):2150-7. PubMed ID: 7743516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
    Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F
    Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelic deletion on chromosome 17p13.3 in early ovarian cancer.
    Phillips NJ; Ziegler MR; Radford DM; Fair KL; Steinbrueck T; Xynos FP; Donis-Keller H
    Cancer Res; 1996 Feb; 56(3):606-11. PubMed ID: 8564979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allele loss on chromosome 1p36 in epithelial ovarian cancers.
    Alvarez AA; Lambers AR; Lancaster JM; Maxwell GL; Ali S; Gumbs C; Berchuck A; Futreal PA
    Gynecol Oncol; 2001 Jul; 82(1):94-8. PubMed ID: 11426968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked allelic imbalance on chromosome 5q31 does not explain alpha-catenin expression in epithelial ovarian cancer.
    Tuhkanen H; Anttila M; Kosma VM; Puolakka J; Juhola M; Heinonen S; Mannermaa A
    Gynecol Oncol; 2004 Aug; 94(2):416-21. PubMed ID: 15297182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A one centimorgan deletion unit on chromosome Xq12 is commonly lost in borderline and invasive epithelial ovarian tumors.
    Edelson MI; Lau CC; Colitti CV; Welch WR; Bell DA; Berkowitz RS; Mok SC
    Oncogene; 1998 Jan; 16(2):197-202. PubMed ID: 9464537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancers.
    Dion F; Mes-Masson AM; Seymour RJ; Provencher D; Tonin PN
    Oncogene; 2000 Mar; 19(11):1466-72. PubMed ID: 10723138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetic changes associated with ovarian cancer.
    Weitzel JN; Patel J; Smith DM; Goodman A; Safaii H; Ball HG
    Gynecol Oncol; 1994 Nov; 55(2):245-52. PubMed ID: 7959292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity of chromosome 17 in human borderline and invasive epithelial ovarian tumors.
    Wertheim I; Tangir J; Muto MG; Welch WR; Berkowitz RS; Chen WY; Mok SC
    Oncogene; 1996 May; 12(10):2147-53. PubMed ID: 8668340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 400 kb novel deletion unit centromeric to the BRCA1 gene in sporadic epithelial ovarian cancer.
    Tangir J; Muto MG; Berkowitz RS; Welch WR; Bell DA; Mok SC
    Oncogene; 1996 Feb; 12(4):735-40. PubMed ID: 8632895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allelic imbalance and microsatellite instability in BRCA1 associated breast and ovarian tumors.
    van der Looij M; Papp J; Sztán M; Pulay T; Elfadil I; Besznyak I; Tóth J; Devilee P; Oláh E
    Int J Oncol; 2001 Apr; 18(4):775-80. PubMed ID: 11251173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic imbalance is not restricted to numerically abnormal chromosomes in epithelial ovarian tumours.
    Evans MF; Herrington CS
    J Pathol; 2001 Nov; 195(4):443-50. PubMed ID: 11745676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping of chromosome 3p deletions in human epithelial ovarian tumors.
    Lounis H; Mes-Masson AM; Dion F; Bradley WE; Seymour RJ; Provencher D; Tonin PN
    Oncogene; 1998 Nov; 17(18):2359-65. PubMed ID: 9811467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a 1300 kilobase deletion unit on chromosome 7q31.3 in invasive epithelial ovarian carcinomas.
    Edelson MI; Scherer SW; Tsui LC; Welch WR; Bell DA; Berkowitz RS; Mok SC
    Oncogene; 1997 Jun; 14(24):2979-84. PubMed ID: 9205105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic loss on chromosome arm 8p: analysis of sporadic epithelial ovarian tumors.
    Brown MR; Chuaqui R; Vocke CD; Berchuck A; Middleton LP; Emmert-Buck MR; Kohn EC
    Gynecol Oncol; 1999 Jul; 74(1):98-102. PubMed ID: 10385558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of p53 gene in the allelic deletion of chromosome 17p in human ovarian tumors.
    Tsao SW; Mok CH; Oike K; Muto M; Goodman HM; Sheets EE; Berkowitz RS; Knapp RC; Lau CC
    Anticancer Res; 1991; 11(6):1975-82. PubMed ID: 1776830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity at chromosome 9q22-31 is a frequent and early event in ovarian tumors.
    Byrom J; Mudaliar V; Redman CW; Jones P; Strange RC; Hoban PR
    Int J Oncol; 2004 May; 24(5):1271-7. PubMed ID: 15067351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allelic imbalance on chromosome 17p13 in borderline (low malignant potential) epithelial ovarian tumors.
    Zanotti KM; Hart WR; Kennedy AW; Belinson JL; Casey G
    Int J Gynecol Pathol; 1999 Jul; 18(3):247-53. PubMed ID: 12090593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor correlation with loss of heterozygosity on chromosome 17p and p53 mutations in ovarian cancers.
    Sakamoto T; Nomura N; Mori H; Wake N
    Gynecol Oncol; 1996 Nov; 63(2):173-9. PubMed ID: 8910623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.